BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
New Zealand Labour Backs Social Media Ban for Under-16s 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
New Zealand Moves to Ban Social Media for Children Under 16 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Trump Buys SpaceX Shares After Record IPO 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Countries Tighten Social Media Bans for Children 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
U.S. Disrupts China-Linked Hacking Campaign Targeting Government Agencies 
Add as a preferred source on Google
Elon Musk's neurotech business Neuralink implanted its gadget in a person for the first time on Sunday, and the patient is "recovering well," the billionaire said on X, formerly known as Twitter, on Monday.
Elon Musk's Neuralink Implants Brain Technology in Human Patients for the First Time
The business is creating a brain implant that will allow people with severe paralysis to operate external technology using just neural inputs. As per CNBC, Neuralink began enrolling patients for its first-in-human clinical study in the autumn after permission from the United States.
As per a blog post, the Food and Drug Administration planned to undertake the research in May. According to an X post, Musk announced on Monday that Neuralink's first product will be named Telepathy.
If the technology works successfully, individuals with severe degenerative diseases such as ALS might one day utilize the implant to communicate or access social media by manipulating cursors and typing with their brains.
Musk wrote, "Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal. "
The in-human clinical study is just one step on Neuralink's journey to commercialization. Medical device businesses must undergo multiple stages of rigorous data safety collection and testing before receiving ultimate FDA clearance. Neuralink does not specify how many human patients will participate in its first-in-human experiment.
Exploring the Frontier: Neuralink Leads in the Brain-Computer Interface Revolution
Neuralink, as part of the burgeoning brain-computer interface, or BCI, business, is likely the best-known firm in the area due to Musk's high profile as CEO of Tesla and SpaceX. A BCI is a device that deciphers brain impulses and converts them into commands for external technology. Numerous businesses, including Synchron, Precision Neuroscience, Paradromics, and Blackrock Neurotech, have developed systems with similar capabilities.
Paradromics plans to begin its first trial with human patients in the first part of this year. Precision Neuroscience completed its first-in-human clinical research last year. In 2021, a patient who got Synchron's BCI utilized it to tweet from CEO Tom Oxley's Twitter account.
